PRESS RELEASE published on 03/27/2023 at 08:00, 3 years 2 months ago Biophytis: Biophytis presented Sarconeos (BIO101) as a possible treatment candidate for long COVID after hospitalization during the 13th annual International Conference on Frailty and Sarcopenia Resea
PRESS RELEASE published on 03/17/2023 at 08:00, 3 years 2 months ago Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program
PRESS RELEASE published on 03/17/2023 at 08:00, 3 years 2 months ago Biophytis annonce un changement de ratio pour son programme d'American Depositary Receipt ('ADR')
PRESS RELEASE published on 03/09/2023 at 08:00, 3 years 3 months ago Biophytis To Present Positive Results of Phase 2-3 COVA Study At ERS 2023 21st Lung Science Conference
PRESS RELEASE published on 03/09/2023 at 08:00, 3 years 3 months ago Biophytis présente les résultats positifs de Phase 2-3 COVA à la 21ème Conférence « Lung Science » - ERS 2023
PRESS RELEASE published on 03/02/2023 at 00:00, 3 years 3 months ago Biophytis annonce la signature d’un accord-cadre avec Intsel Chimos, laboratoire pharmaceutique qui exploitera Sarconeos (BIO101) en France pour le traitement des formes sévère de COVID-19
PRESS RELEASE published on 03/02/2023 at 00:00, 3 years 3 months ago Biophytis announces the signature of a master service agreement with Intsel Chimos, a pharmaceutical company that will operate Sarconeos (BIO101) in France for the treatment of severe forms of COVID-1
PRESS RELEASE published on 02/27/2023 at 08:00, 3 years 3 months ago Biophytis: Biophytis démarre le processus règlementaire de demande d’autorisation d’accès précoce en France auprès de la Haute Autorité de Santé (HAS) pour le traitement avec Sarconeos (BIO101) des fo
PRESS RELEASE published on 02/27/2023 at 08:00, 3 years 3 months ago Biophytis initiates the regulatory process for an early access authorization in France from the French National Authority for Health (HAS) for the treatment with Sarconeos (BIO101) of severe forms of
PRESS RELEASE published on 02/23/2023 at 08:00, 3 years 3 months ago : Biophytis To Host A Combined General Shareholder’s Meeting On March 30, 2023
Published on 06/10/2026 at 13:00, 1 hour 28 minutes ago Galway Metals Reports 5.0 g/t Gold over 10.85 Metres at North Deposit and Continues to Intersect Gold in Northern Extension
Published on 06/10/2026 at 13:00, 1 hour 28 minutes ago Jaguar Mining Inc. Accelerates 5-Year Exploration Plan with Tier 1 Drilling Partnerships
Published on 06/10/2026 at 13:00, 1 hour 28 minutes ago Rocky Shore Gold Discovers Bulk-Style Gold Zone at the Gold Anchor Project, Drill Program Expands From 3,500 Metres to 12,500 Metres
Published on 06/10/2026 at 12:50, 1 hour 38 minutes ago Leggett & Platt Automotive Launches New Brand Identity: Leggett Dynamics
Published on 06/10/2026 at 14:03, 24 minutes ago Diginex Appoints Carole Zibi as Chief Marketing Officer
Published on 06/10/2026 at 14:00, 28 minutes ago New Product Debut | YASC Showcases Multiple New Products at PCIM Europe 2026
Published on 06/10/2026 at 13:25, 1 hour 3 minutes ago ams-OSRAM AG: All voting items on the agenda at the Annual General Meeting of the ams-OSRAM AG approved by a clear majority
Published on 06/10/2026 at 13:02, 1 hour 25 minutes ago Mutares has signed an agreement to sell NEM Energy Group to Hyundai Heavy Industries Power Systems (“HPS”)
Published on 06/10/2026 at 11:19, 3 hours 9 minutes ago Electricité de Strasbourg - Informations sur les droits de vote au jour de l'AG
Published on 06/10/2026 at 07:00, 7 hours 28 minutes ago Acceleration of Museum Studio's international expansion
Published on 06/10/2026 at 07:00, 7 hours 28 minutes ago Accélération de l'expansion mondiale de Museum Studio
Published on 06/09/2026 at 19:30, 18 hours 58 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL
Published on 06/09/2026 at 19:30, 18 hours 58 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
